Burns, S. S., Akhmametyeva, E. M., Oblinger, J. L., Bush, M. L., Huang, J., Senner, V., . . . Chang, L. (2012). Histone deacetylase inhibitor AR-42 differentially affects cell cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.

Burns, Sarah S., et al. Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell Cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2-deficient Meningioma Growth. 2012.

Burns, Sarah S., et al. Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell Cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2-deficient Meningioma Growth. 2012.